COMMUNIQUÉS West-GlobeNewswire

-
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives
28/02/2025 - 22:05 -
4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones
28/02/2025 - 22:05 -
Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance
27/02/2025 - 22:01 -
WW International, Inc. Announces Fourth Quarter and Full Year 2024 Results
27/02/2025 - 22:01 -
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
27/02/2025 - 22:01 -
Celldex Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
27/02/2025 - 22:01 -
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024
27/02/2025 - 22:01 -
Standard BioTools to Participate in Upcoming Investor Conferences
27/02/2025 - 22:01 -
Progyny, Inc. Announces Fourth Quarter 2024 Results
27/02/2025 - 22:01 -
NurExone Biologic to Present at MIXiii 2025; Professor Michael Belkin, Head of NurExone Ophthalmology Project, to Receive Lifetime Achievement Award
27/02/2025 - 22:03 -
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2024
27/02/2025 - 22:03 -
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights
27/02/2025 - 22:05 -
Ventyx Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Corporate Progress
27/02/2025 - 22:05 -
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
27/02/2025 - 22:05 -
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook
27/02/2025 - 22:05 -
Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial Results
27/02/2025 - 22:05 -
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
27/02/2025 - 22:05 -
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
27/02/2025 - 22:05 -
89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
27/02/2025 - 22:05
Pages